None listed
Conditions
Brief summary
The purpose of this project is to assess the efficacy and acceptability of a remotely delivered transdiagnostic cognitive behavioural treatment for perinatal anxiety in an Australian sample. Participants are asked to complete standardised questionnaire measures at pre-treatment, post-treatment, and 3 month follow up, and brief weekly questionnaires throughout treatment to monitor participants’ symptoms and safety throughout treatment. Treatment will consist of 5 x 50-minute weekly sessions, which will be conducted via the secure online platform, Zoom. It is hypothesised that participants self-reported symptoms of perinatal anxiety will reduce from pre-treatment to post-treatment and that participants will no longer meet diagnostic criteria for anxiety.
Interventions
Treatment will consist of 5 x 50 minute weekly CBT sessions, which will be conducted via the secure online platform, Zoom. Sessions will be recorded for quality and supervision purposes. The intervention will be delivered via the student researcher, Peta Maguire, who is a registered psychologist. Participants will be required to complete weekly brief questionnaires so that the clinician can monitor participants symptoms. The session outline for the treatment is below:
Session 1: Psychoeducatio
Treatment will consist of 5 x 50 minute weekly CBT sessions, which will be conducted via the secure online platform, Zoom. Sessions will be recorded for quality and supervision purposes. The intervention will be delivered via the student researcher, Peta Maguire, who is a registered psychologist. Participants will be required to complete weekly brief questionnaires so that the clinician can monitor participants symptoms. The session outline for the treatment is below: Session 1: Psychoeducation • Psychoeducation • Developing a CBT model • Homework: Symptom Monitoring Diary Session 2: Cognitive Restructuring • Homework check-in • Introduction to automatic thoughts • Identifying and challenging unhelpful automatic thoughts • Homework: Unhelpful Thinking Worksheet Session 3: Arousal Reduction • Homework check-in • Controlling physical symptoms using de-arousal strategies • Homework: Arousal reduction strategies Session 4: Exposure • Homework check-in • Identifying maladaptive behaviours • Education about graded exposure • Constructing an exposure stepladder • Homework: Graded exposure task Session 5: Relapse Prevention • Homework check in • Developing a relapse prevention plan • Extra resources
Sponsors
University of New England
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
(a) Currently in the first 10 months postpartum (participants must be within 10 months postpartum to ensure treatment is delivered during the perinatal period); (b) Proficient in English; (c) 18 years of age or above; (d) Have regular access to the internet; (e) Meet DSM-5 diagnostic criteria for an anxiety or related disorder as primary (as determined by the DIAMOND); (f) No history of psychotic illness or bipolar disorder; (g) A score of at least 8 on the Overall Anxiety Severity and Impairment Scale (OASIS) (h) If using medication, the medication is a stable dose (i) Does not report suicidal ideation and intent (as identified through risk related questions during interview) (j) Does not report recent (i.e., past 3 months) suicide attempts or deliberate self-harm (k) Does not report past or present psychosis (assessed using the DIAMOND) (l) A score of below 3 on item 10 of the Edinburgh Postnatal Depression Scale (EPDS)
Exclusion criteria
(a) Currently not in the first 10 months postpartum (b) Not proficient in English (c) Under 18years of age (d) Do not have regular access to the internet (e) Does not endorse one of the anxiety and related disorders on the DIAMOND screener (f) History of a psychotic illness or bipolar disorder (g) Does not have a score of at least 8 on the Overall Anxiety Severity and Impairment Scale (OASIS) (h) Not on a stable dose of pharmacological medication (i) Report suicidal ideation and intent (as identified through risk related questions during interview). (j) Recent (i.e., past 3 months) suicide attempts or deliberate self-harm (k) Report past or present psychosis (assessed using the DIAMOND) (l) Are at high risk of suicide as determined by a score of 3 on item 10 of the Edinburgh Postnatal Depression Scale (EPDS).
Outcome results
None listed